{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:12:24Z","timestamp":1761419544843,"version":"3.40.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cpcardiol.2023.101632","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:49:41Z","timestamp":1675003781000},"page":"101632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimal Anticoagulation on TAVI Patients Based on Thrombotic and Bleeding Risk and the Challenge Beyond: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8170-8275","authenticated-orcid":false,"given":"Ioannis","family":"Tsoumas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asena","family":"Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2021","series-title":"Aortic Stenosis in the Elderly","author":"Osnabrugge","key":"10.1016\/j.cpcardiol.2023.101632_bib0001"},{"journal-title":"New Heart Valve","article-title":"Aortic Stenosis Causes, Symptoms, and Progression | What Is Aortic Stenosis? [Internet]","year":"2021","key":"10.1016\/j.cpcardiol.2023.101632_bib0002"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0003","article-title":"Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS\/AI similar in different parts of the world? [Internet]","author":"Ancona'","year":"2021","journal-title":"Escardio.org"},{"journal-title":"Escardio.org","article-title":"[Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis [Internet]","year":"2021","key":"10.1016\/j.cpcardiol.2023.101632_bib0004"},{"year":"2021","series-title":"[Internet]","author":"Armijo","key":"10.1016\/j.cpcardiol.2023.101632_bib0005"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0006","series-title":"JACC. Cardiovascular interventions. U.S. National Library of Medicine","article-title":"Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement [Internet]","author":"Piccolo","year":"2021"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0007","article-title":"Antithrombotic management after transcatheter aortic valve implantation [Internet]","author":"McHugh","year":"2021","journal-title":"J Thoracic Dis US Natl Libr Med"},{"year":"2020","series-title":"Direct oral anticoagulants versus Vitamin K antagonists in patients with atrial fibrillation after TAVR [Internet]","author":"Kawashima","key":"10.1016\/j.cpcardiol.2023.101632_bib0011"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0012","article-title":"Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis","author":"Zhu","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after Trans-aortic valve implantation for aortic stenosis: the randomized Atlantis trial [Internet]","author":"Collet","year":"2018","journal-title":"Am Heart J Mosby"},{"year":"2021","series-title":"Apixaban not superior to standard care after TAVR [Internet]","key":"10.1016\/j.cpcardiol.2023.101632_bib0016"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0017","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research: [Internet]","author":"G\u00e9n\u00e9reux","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0018","article-title":"Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation [Internet]","author":"Rod\u00e9s-Cabau","year":"2022","journal-title":"J Am Coll Cardiol"},{"journal-title":"Eur J Cardio-Thoracic Surg","year":"2022","author":"Capodanno","key":"10.1016\/j.cpcardiol.2023.101632_bib0019"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jcin.2014.11.020","article-title":"Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality","volume":"8","author":"O\u2013Sullivan","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0021","volume":"10","author":"Josep","year":"2017","journal-title":"JACC"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0022","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","author":"Brouwer","year":"2023","journal-title":"N Engl J Med"},{"journal-title":"Am Coll Cardiol","article-title":"Antithrombotic therapy after transcatheter aortic valve implantation in patients with a long-term indication for oral anticoagulation [Internet]","year":"2020","key":"10.1016\/j.cpcardiol.2023.101632_bib0023"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2018.10.047","article-title":"Tailoring antiplatelet therapy in patients undergoing transcatheter aortic valve replacement","author":"Capodanno","year":"2019","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0025","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2019.10","article-title":"Antithrombotic therapy after transcatheter aortic valve implantation [Internet]","author":"Lugo","year":"2020","journal-title":"Eur Cardiol Radcliffe Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0026","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement: Nejm [Internet]","author":"Dangas","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0027","article-title":"* Corresponding Author; email: E-mail Address: [email&nbsp;protected] 0000-0001-6643-0239","author":"Park","year":"2022","journal-title":"Div Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0028","unstructured":"Edoxaban compared to standard care after heart valve replacement using a catheter in patients with atrial fibrillation (envisage-tavi AF) - full text view [Internet]. Full Text View - ClinicalTrials.gov. [cited 2022 Apr30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02943785"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0029","article-title":"Investigators* for the ENVISAGE-TAVIAF, Author Affiliations From the Department of Cardiology. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR: Nejm [Internet]","author":"Mieghem","year":"2022","journal-title":"New Engl J Med"},{"journal-title":"American College of Cardiology","article-title":"Edoxaban vs. standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation\u2013atrial fibrillation [Internet]","year":"2021","key":"10.1016\/j.cpcardiol.2023.101632_bib0030"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0031","article-title":"TAVR patients requiring anticoagulation: Direct oral anticoagulant or Vitamin K antagonist? [Internet]","author":"Didier","year":"2021","journal-title":"JACC"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0032","article-title":"Use of direct oral anticoagulant and outcomes in patients with atrial fibrillation after transcatheter aortic valve replacement: Insights from the STS\/ACC TVT registry [Internet]","author":"Tanawuttiwat","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0033","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ancard.2017.10.009","article-title":"Valve thrombois post-TAVI","volume":"66","author":"Leguay","year":"2017","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779","article-title":"Treatment and clinical outcomes of transcatheter heart valve thrombosis","volume":"8","author":"Latib","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2023.101632_bib0036","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2021.05.047","article-title":"Comparison of ticagrelor versus clopidogrel on cerebrovascular microembolic events and platelet inhibition during transcatheter aortic valve implantation","volume":"154","author":"Vavuranakis","year":"2021","journal-title":"Am J Cardiol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:03:54Z","timestamp":1729076634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014628062300049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S014628062300049X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101632","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Anticoagulation on TAVI Patients Based on Thrombotic and Bleeding Risk and the Challenge Beyond: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101632"}}